REID COLLINS & TSAI LLP RECOVERS $175 MILLION SETTLEMENT FROM FORMER INSYS DIRECTORS IN OPIOID-RELATED LAWSUIT

• National trial firm Reid Collins & Tsai LLP represents Insys Liquidation Trust in lawsuit against former directors of Insys Therapeutics, a public company which played a key role in the national opioid crisis.
• Lawsuit alleges that failures of oversight by the former directors enabled company's officers to engage in unlawful scheme to sell and market a dangerous fentanyl spray in violation of multiple federal and state statutes.
• Settlement terms include $175 million judgment against the former directors, partial payment from their personal assets, and assignment of their claims to recover the balance from insurance companies.

AUSTIN, Texas, April 14, 2023 /PRNewswire/ -- Today, national trial firm Reid Collins & Tsai LLP ("Reid Collins") representing the Insys Liquidation Trust (the "Trust") announced a $175 million settlement agreement with certain former directors of Insys Therapeutics, Inc. ("Insys"), partially resolving civil litigation arising from its bankruptcy case.

Insys, a former public company, marketed and sold a highly addictive and inherently dangerous fentanyl spray to millions of people. The Trust, as the successor to Insys, alleges in its lawsuit that the company's executives engaged in a multi-faceted unlawful scheme involving off-label marketing of the drug (non-FDA approved uses), titration of drug dosages (higher than FDA-approved doses), and payment of bribes and other kickbacks to doctors who prescribed the drug.

Due to the alleged misconduct, Insys and its executives became the target of multiple criminal proceedings, class actions, and other civil cases, as well as intense media scrutiny, including an HBO documentary and feature stories on 60 Minutes, Frontline, and NBC News. Ultimately, several of the company's executives were convicted of racketeering charges, and the company agreed to a $225 million settlement with the federal government before collapsing into bankruptcy.

The Trust, as the successor to Insys in its bankruptcy case, then brought a lawsuit against the former directors of the company, alleging that their failures of oversight enabled this unlawful sales and marketing scheme. The Trust has settled its claims with the company's former outside directors— Patrick Fourteau, Pierre Lapalme, Steven Meyer, and Brian Tambi. The settlement includes a $175 million judgment against these former directors, a partial payment from their personal assets, and assignment of their claims to recover the balance from XL Specialty Insurance Company and other insurers that issued D&O policies to Insys and its directors.

Reid Collins partner Eric D. Maddenhttps://reidcollins.com/person/p-jason-collins/, who leads the prosecution of the lawsuit, on the settlement's significance: "The alleged misconduct by defendants in this case contributed to the opioid crisis in this country and the demise of the company. The $175 million settlement, a substantial portion of the damages sought by the Trust, is an excellent result for the company's creditors, the culmination of hard-fought litigation and extensive negotiations, and comprised in part from personal assets of the defendants."

Madden further stated: "This settlement is also noteworthy as a successful resolution of a Caremark claim, which Delaware courts have described as 'possibly the most difficult theory in corporation law upon which a plaintiff might hope to win a judgment.'"

Reid Collins was retained as special litigation counsel to investigate and pursue claims on behalf of the Trust in early 2021, after an extensive interview process. The Insys bankruptcy case is captioned In re Insys Therapeutics, Inc., No. 19-11292 (Bankr. D. Del.), and the Trust's lawsuit is captioned Henrich v. Kapoor, et al., C.A. No. 12696-JTL (Del. Ch.). The Trust's claims in that lawsuit remain pending against John Kapoor and Michael Babich, the company's former Chairman and CEO, who were convicted on racketeering charges.

About Reid Collins

Reid Collins & Tsai LLP is one of the nation's leading plaintiffs' trial firms, litigating complex business disputes and achieving billions of dollars in settlements and judgments for its clients. Its team is comprised of accomplished trial lawyers who have extensive experience prosecuting financial fraud, corporate wrongdoing, bankruptcy and insolvency related litigation, employment and partnership disputes, professional liability claims, and cross-border disputes. The firm represents fund managers, investor groups, trustees, receivers, liquidators, international banks, companies, governmental entities, and individuals in federal and state courts across the country.

For more information visit www.reidcollins.com

Austin | Dallas | New York | Washington D.C. | Wilmington

Contact:
Alexander Coxe
212.365.4792
acoxe@reidcollins.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/reid-collins--tsai-llp-recovers-175-million-settlement-from-former-insys-directors-in-opioid-related-lawsuit-301798083.html

SOURCE Reid Collins & Tsai LLP